Biogen’s mid-stage trial of diranersen did not meet its main goal of showing a clear relationship between higher doses and ...
18hon MSN
Why is Biogen stock falling Tuesday?
Biogen Inc. BIIB on Tuesday said it will advance investigational Alzheimer’s therapy diranersen into Phase 3 testing after ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Biogen could see more upside if it publishes positive results from recent trials linked to kidney and Alzheimer's treatments, ...
Shares of Biogen BIIB rose nearly 5% yesterday after the company announced that the FDA approved a subcutaneous (SC) ...
IBM’s preliminary second-quarter earnings miss estimates and the stock falls sharply.
Patients with mild cognitive impairment or mild dementia due to Alzheimer's can now begin treatment with a subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results